Syros to launch concurrent public offerings of common stock, preferred stock & warrants Syros Pharmaceuticals (SYRS), down 4.8% after it filed to sell $40M in common stock. On The Fly: After Hours Movers As he sends his soldiers off on their mission, he warns: "If women wax woode; /...